Radiation techniques for acromegaly

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Minniti, Giuseppe ^a,b   Scaringi, Claudia ^b   Enrici, Riccardo M ^b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acromegaly; Fractionated stereotactic radiotherapy; Gh secreting pituitary tumors; Radiosurgery; Toxicity

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADVERSE OUTCOME; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; GLIOMA; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPITUITARISM; INTENSITY MODULATED RADIATION THERAPY; MENINGIOMA; METASTASIS; PRIMARY TUMOR; RADIATION INDUCED NEOPLASM; RADIATION INJURY; REVIEW; STEREOTACTIC RADIOSURGERY; STEREOTACTIC RADIOTHERAPY; STEREOTACTIC TREATMENT; ADENOMA; HYPOPHYSIS TUMOR; METHODOLOGY; RADIATION DOSE FRACTIONATION; RADIOTHERAPY;

ACROMEGALY; ADENOMA; DOSE FRACTIONATION; HUMANS; HYPOPITUITARISM; PITUITARY NEOPLASMS; RADIOTHERAPY;

EID: 82455168222     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-167     Document Type: Review

References (54)

1. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004, 25:102-152. 10.1210/er.2002-0022, 14769829.
2. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 2003, 10:611-619. 10.1677/erc.0.0100611, 14713271.
3. Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol(Oxf) 2001, 55:307-313.
4. Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G, Cassone R. Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol 2003, 148:193-201. 10.1530/eje.0.1480193, 12590638.
5. Melmed S. Medical progress: Acromegaly. N Engl J Med 2006, 355:2558-2573. 10.1056/NEJMra062453, 17167139.
6. Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 2009, 10:135-144. 10.1007/s11154-008-9106-0, 18787957.
7. Brada M, Ajithkumar TV, Minniti G. Radiosurgery for pituitary adenomas. Clin Endocrinol (Oxf) 2004, 61:531-543.
8. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997, 82:3187-3191. 10.1210/jc.82.10.3187, 9329336.
9. Thalassinos NC, Tsagarakis S, Ioannides G, Tzavara I, Papavasiliou C. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: a long-term follow-up study. Eur J Endocrinol 1998, 138:160-163. 10.1530/eje.0.1380160, 9506859.
10. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 2000, 85:3779-3785. 10.1210/jc.85.10.3779, 11061538.
11. Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000, 85:2476-2482. 10.1210/jc.85.7.2476, 10902796.
12. Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R. Failure of radiotherapy in acromegaly. Eur J Endocrinol 2001, 145:717-726. 10.1530/eje.0.1450717, 11720896.
13. Epaminonda P, Porretti S, Cappiello V, Beck-Peccoz P, Faglia G, Arosio M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol (Oxf) 2001, 55:183-189.
14. Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G, Enrici RM. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 2005, 62:210-216.
15. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 2006, 91:1239-1245. 10.1210/jc.2005-1616, 16403824.
16. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S. Acromegaly Consensus Group. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010, 95:3141-3148. 10.1210/jc.2009-2670, 20410227.
17. Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 2002, 57:713-717.
18. Erfurth EM, Bülow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Björk J, Hagmar L. Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 2002, 87:4892-4899. 10.1210/jc.2002-020526, 12414846.
19. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993, 72:2227-2233. 10.1002/1097-0142(19931001)72:7<2227::AID-CNCR2820720727>3.0.CO;2-I, 8374881.
20. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 2005, 90:800-804.
21. Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 2009, 8:810-818. 10.1016/S1474-4422(09)70204-2, 19665931.
22. Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE. Cognitive dysfunction in patients treated for pituitary tumours. J Clin Exp Neuropsychol 1997, 19:1-6. 10.1080/01688639708403831, 9071636.
23. Noad R, Narayanan KR, Howlett T, Lincoln NB, Page RC. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin Oncol (R Coll Radiol) 2004, 16:233-237.
24. Tooze A, Gittoes NJ, Jones CA, Toogood AA. Neurocognitive consequences of surgery and radiotherapy for tumours of the pituitary. Clin Endocrinol (Oxf) 2009, 70:503-511.
25. Minniti G, Valeriani M, Clarke E, D'Arienzo M, Ciotti M, Montagnoli R, Saporetti F, Enrici RM. Fractionated stereotactic radiotherapy for skull base tumors: analysis of treatment accuracy using a stereotactic mask fixation system. Radiat Oncol 2010, 5:1. 10.1186/1748-717X-5-1, 2823752, 20070901.
26. Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 2004, 59:1088-1096. 10.1016/j.ijrobp.2003.12.012, 15234043.
27. Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, Lukas C, Bazin A, Bernard MH, Scherpereel B, Peruzzi P, Nakib I, Redon C, Rousseaux P. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 2005, 62:333-341. 10.1016/j.ijrobp.2004.09.058, 15890572.
28. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 2006, 64:542-548.
29. Roug S, Rasmussen AK, Juhler M, Kosteljanetz M, Poulsgaard L, Heebøll H, Roed H, Feldt-Rasmussen U. Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur J Endocrinol 2010, 162:685-694. 10.1530/EJE-09-1045, 20133445.
30. Mackley HB, Reddy CA, Lee SY, Harnisch GA, Mayberg MR, Hamrahian AH, Suh JH. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 2007, 67:232-239. 10.1016/j.ijrobp.2006.08.039, 17084541.
31. Merchant TE. Proton beam therapy in pediatric oncology. Cancer J 2009, 15:298-305. 10.1097/PPO.0b013e3181b6d4b7, 19672146.
32. Petit JH, Biller BM, Coen JJ, Swearingen B, Ancukiewicz M, Bussiere M, Chapman P, Klibanski A, Loeffler JS. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 2007, 13:726-734.
33. Ronson BB, Schulte RW, Han KP, Loredo LN, Slater JM, Slater JD. Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys 2006, 64:425-434. 10.1016/j.ijrobp.2005.07.978, 16257131.
34. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003, 88:3105-3112. 10.1210/jc.2002-021663, 12843150.
35. Jane JA, Vance ML, Woodburn CJ, Laws ER. Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 2003, 14:e12.
36. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Régis J, Dufour H, Brue T. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 2005, 90:4483-4488. 10.1210/jc.2005-0311, 15899958.
37. Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 2005, 113:219-224. 10.1055/s-2005-837552, 15891958.
38. Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S. Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure?. J Neurosurg 2005, 102(Suppl):119-123. 10.3171/jns.2005.102.s_supplement.0119, 16206746.
39. Jezková J, Marek J, Hána V, Krsek M, Weiss V, Vladyka V, Lisák R, Vymazal J, Pecen L. Gamma knife radiosurgery for acromegaly--long-term experience. Clin Endocrinol (Oxf) 2006, 64:588-595.
40. Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, Maarouf M, Gouni-Berthold I, Krone W, Muller RP, Sturm V. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 2006, 107:1355-1364. 10.1002/cncr.22128, 16894526.
41. Pollock BE, Jacob JT, Brown PD, Nippoldt TB. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 2007, 106:833-838. 10.3171/jns.2007.106.5.833, 17542527.
42. Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M. Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol 2007, 157:255-263. 10.1530/EJE-07-0189, 17766706.
43. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 2008, 62:1262-1269. 10.1227/01.neu.0000333297.41813.3d, 18824992.
44. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, Mortini P. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 2008, 93:2546-2552. 10.1210/jc.2008-0135, 18413424.
45. Ronchi CL, Attanasio R, Verrua E, Cozzi R, Ferrante E, Loli P, Montefusco L, Motti E, Ferrari DI, Giugni E, Beck-Peccoz P, Arosio M. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. Clin Endocrinol (Oxf) 2009, 71:846-852.
46. Wan H, Chihiro O, Yuan S. MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res 2009, 28:36. 10.1186/1756-9966-28-36, 2660297, 19284583.
47. Hayashi M, Chernov M, Tamura N, Nagai M, Yomo S, Ochiai T, Amano K, Izawa M, Hori T, Muragaki Y, Iseki H, Okada Y, Takakura K. Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases. J Neurooncol 2010, 98:185-194. 10.1007/s11060-010-0172-2, 20411299.
48. Iwai Y, Yamanaka K, Yoshimura M, Kawasaki I, Yamagami K, Yoshioka K. Gamma knife radiosurgery for growth hormone-producing adenomas. J Clin Neurosci 2010, 17:299-304. 10.1016/j.jocn.2009.05.040, 20071176.
49. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 1998, 88:1002-1008. 10.3171/jns.1998.88.6.1002, 9609294.
50. Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery: tip of the iceberg or a bump in the road?. Neurosurgery 2003, 52:1436-1440. 10.1227/01.NEU.0000064809.59806.E8, 12762888.
51. Adler JR, Gibbs IC, Puataweepong P, Chang SD. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 2006, 59:244-254. 10.1227/01.NEU.0000223512.09115.3E, 16883165.
52. Kajiwara K, Saito K, Yoshikawa K, Kato S, Akimura T, Nomura S, Ishihara H, Suzuki M. Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 2005, 48:91-96. 10.1055/s-2004-830261, 15906203.
53. Roberts BK, Ouyang DL, Lad SP, Chang SD, Harsh GR, Adler JR, Soltys SG, Gibbs IC, Remedios L, Katznelson L. Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 2007, 10:19-25. 10.1007/s11102-007-0004-3, 17273921.
54. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC. Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir (Wien) 1998, 140:437-443.